Logo image of HSIC

HENRY SCHEIN INC (HSIC) Stock Fundamental Analysis

NASDAQ:HSIC - Nasdaq - US8064071025 - Common Stock - Currency: USD

71.46  -1.16 (-1.6%)

After market: 71.045 -0.41 (-0.58%)

Fundamental Rating

4

Overall HSIC gets a fundamental rating of 4 out of 10. We evaluated HSIC against 103 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HSIC get a neutral evaluation. Nothing too spectacular is happening here. HSIC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

HSIC had positive earnings in the past year.
In the past year HSIC had a positive cash flow from operations.
In the past 5 years HSIC has always been profitable.
Each year in the past 5 years HSIC had a positive operating cash flow.
HSIC Yearly Net Income VS EBIT VS OCF VS FCFHSIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.88%, HSIC is in the better half of the industry, outperforming 71.84% of the companies in the same industry.
With a decent Return On Equity value of 12.30%, HSIC is doing good in the industry, outperforming 77.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.05%, HSIC is in the better half of the industry, outperforming 68.93% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HSIC is in line with the industry average of 9.70%.
Industry RankSector Rank
ROA 3.88%
ROE 12.3%
ROIC 7.05%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
HSIC Yearly ROA, ROE, ROICHSIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 3.21%, HSIC is in the better half of the industry, outperforming 66.99% of the companies in the same industry.
In the last couple of years the Profit Margin of HSIC has declined.
HSIC has a better Operating Margin (6.13%) than 65.05% of its industry peers.
HSIC's Operating Margin has declined in the last couple of years.
HSIC's Gross Margin of 31.60% is in line compared to the rest of the industry. HSIC outperforms 56.31% of its industry peers.
In the last couple of years the Gross Margin of HSIC has remained more or less at the same level.
Industry RankSector Rank
OM 6.13%
PM (TTM) 3.21%
GM 31.6%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
HSIC Yearly Profit, Operating, Gross MarginsHSIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HSIC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HSIC has been reduced compared to 5 years ago.
HSIC has a worse debt/assets ratio than last year.
HSIC Yearly Shares OutstandingHSIC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HSIC Yearly Total Debt VS Total AssetsHSIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

HSIC has an Altman-Z score of 2.83. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.83, HSIC is in the better half of the industry, outperforming 61.16% of the companies in the same industry.
HSIC has a debt to FCF ratio of 5.69. This is a neutral value as HSIC would need 5.69 years to pay back of all of its debts.
HSIC's Debt to FCF ratio of 5.69 is fine compared to the rest of the industry. HSIC outperforms 61.16% of its industry peers.
HSIC has a Debt/Equity ratio of 0.86. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.86, HSIC perfoms like the industry average, outperforming 41.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 5.69
Altman-Z 2.83
ROIC/WACC0.88
WACC8.05%
HSIC Yearly LT Debt VS Equity VS FCFHSIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

HSIC has a Current Ratio of 1.38. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HSIC (1.38) is comparable to the rest of the industry.
A Quick Ratio of 0.75 indicates that HSIC may have some problems paying its short term obligations.
The Quick ratio of HSIC (0.75) is worse than 78.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.75
HSIC Yearly Current Assets VS Current LiabilitesHSIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

HSIC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.11%, which is quite good.
Measured over the past 5 years, HSIC shows a small growth in Earnings Per Share. The EPS has been growing by 6.19% on average per year.
Looking at the last year, HSIC shows a small growth in Revenue. The Revenue has grown by 1.75% in the last year.
HSIC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.88% yearly.
EPS 1Y (TTM)9.11%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%4.55%
Revenue 1Y (TTM)1.75%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%-0.13%

3.2 Future

HSIC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.69% yearly.
The Revenue is expected to grow by 3.67% on average over the next years.
EPS Next Y4.86%
EPS Next 2Y6.57%
EPS Next 3Y7.88%
EPS Next 5Y7.69%
Revenue Next Year1.43%
Revenue Next 2Y2.49%
Revenue Next 3Y3.01%
Revenue Next 5Y3.67%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HSIC Yearly Revenue VS EstimatesHSIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
HSIC Yearly EPS VS EstimatesHSIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.92, which indicates a correct valuation of HSIC.
Compared to the rest of the industry, the Price/Earnings ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 75.73% of the companies listed in the same industry.
HSIC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.04.
Based on the Price/Forward Earnings ratio of 13.28, the valuation of HSIC can be described as correct.
HSIC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HSIC is cheaper than 75.73% of the companies in the same industry.
HSIC is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.92
Fwd PE 13.28
HSIC Price Earnings VS Forward Price EarningsHSIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 65.05% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 65.05% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.58
EV/EBITDA 10.22
HSIC Per share dataHSIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSIC does not grow enough to justify the current Price/Earnings ratio.
HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.07
PEG (5Y)2.41
EPS Next 2Y6.57%
EPS Next 3Y7.88%

0

5. Dividend

5.1 Amount

No dividends for HSIC!.
Industry RankSector Rank
Dividend Yield N/A

HENRY SCHEIN INC

NASDAQ:HSIC (7/25/2025, 8:00:01 PM)

After market: 71.045 -0.41 (-0.58%)

71.46

-1.16 (-1.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-05 2025-05-05/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners95.25%
Inst Owner Change0.12%
Ins Owners0.74%
Ins Owner Change6.34%
Market Cap8.93B
Analysts73.91
Price Target77.2 (8.03%)
Short Float %6.69%
Short Ratio4.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.87%
Min EPS beat(2)-3.32%
Max EPS beat(2)1.57%
EPS beat(4)2
Avg EPS beat(4)-0.07%
Min EPS beat(4)-3.32%
Max EPS beat(4)2.52%
EPS beat(8)4
Avg EPS beat(8)-0.25%
EPS beat(12)4
Avg EPS beat(12)-1.28%
EPS beat(16)8
Avg EPS beat(16)2.07%
Revenue beat(2)0
Avg Revenue beat(2)-4.41%
Min Revenue beat(2)-5.06%
Max Revenue beat(2)-3.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.63%
Min Revenue beat(4)-5.88%
Max Revenue beat(4)-3.77%
Revenue beat(8)0
Avg Revenue beat(8)-3.82%
Revenue beat(12)0
Avg Revenue beat(12)-3.76%
Revenue beat(16)3
Avg Revenue beat(16)-2.16%
PT rev (1m)-0.56%
PT rev (3m)-4.6%
EPS NQ rev (1m)-0.32%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 14.92
Fwd PE 13.28
P/S 0.71
P/FCF 17.58
P/OCF 12.98
P/B 2.7
P/tB N/A
EV/EBITDA 10.22
EPS(TTM)4.79
EY6.7%
EPS(NY)5.38
Fwd EY7.53%
FCF(TTM)4.06
FCFY5.69%
OCF(TTM)5.5
OCFY7.7%
SpS101.35
BVpS26.48
TBVpS-13.39
PEG (NY)3.07
PEG (5Y)2.41
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 12.3%
ROCE 10.27%
ROIC 7.05%
ROICexc 7.15%
ROICexgc 17.9%
OM 6.13%
PM (TTM) 3.21%
GM 31.6%
FCFM 4.01%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexcg growth 3Y-9.94%
ROICexcg growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score7
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 5.69
Debt/EBITDA 2.64
Cap/Depr 60.61%
Cap/Sales 1.42%
Interest Coverage 5.63
Cash Conversion 64.06%
Profit Quality 124.82%
Current Ratio 1.38
Quick Ratio 0.75
Altman-Z 2.83
F-Score7
WACC8.05%
ROIC/WACC0.88
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)9.11%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%4.55%
EPS Next Y4.86%
EPS Next 2Y6.57%
EPS Next 3Y7.88%
EPS Next 5Y7.69%
Revenue 1Y (TTM)1.75%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%-0.13%
Revenue Next Year1.43%
Revenue Next 2Y2.49%
Revenue Next 3Y3.01%
Revenue Next 5Y3.67%
EBIT growth 1Y17.55%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year16.31%
EBIT Next 3Y8.77%
EBIT Next 5YN/A
FCF growth 1Y18.69%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y28.36%
OCF growth 3Y6.12%
OCF growth 5Y4.66%